Literature DB >> 18548585

Chronic rhinosinusitis and risk of lung cancer in the Singapore Chinese Health Study.

Woon-Puay Koh1, Jian-Min Yuan, Renwei Wang, Adeline Seow, Hin-Peng Lee, Mimi C Yu.   

Abstract

Epidemiologic evidence suggests that chronic inflammatory conditions of the lung may increase lung cancer risk. These chronic conditions, such as chronic obstructive pulmonary disease and asthma, commonly coexist with chronic rhinosinusitis. We prospectively examined if chronic rhinitis or sinusitis was associated with lung cancer risk in the Singapore Chinese Health Study, a population-based cohort of 63,257 Singapore Chinese, who were aged 45-74 years when recruited between 1993 and 1998. Each subject completed a comprehensive interview on medical conditions, dietary and lifestyle factors at recruitment, and cancer occurrence and survival status were determined via linkage to population-based registries. As of 31 December, 2005, 954 cohort participants had developed lung cancer. Compared with subjects without such history, subjects who reported a history of physician-diagnosed rhinitis or sinusitis at baseline, whether allergic or nonallergic, had a statistically significant 59% increase in risk of lung cancer (hazard ratio [HR] = 1.59; confidence interval [CI] = 1.06-2.37). This association was significant and stronger in women (HR = 2.32; 95% CI = 1.23-4.39) compared to men, and for the adenocarcinoma cell type (HR = 1.91; 95% CI = 1.07-3.42) compared to other histologies. Overall, a history of asthma, hay fever, allergic dermatitis, food allergy or any other allergic conditions asked in a single question was not related to lung cancer risk (HR = 1.11; 95% CI = 0.90-1.36). Chronic rhinosinusitis may be a marker of pan-airway inflammation and its association with lung cancer risk provides evidence linking inflammation to lung carcinogenesis, especially among women. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18548585      PMCID: PMC2728457          DOI: 10.1002/ijc.23623

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  51 in total

1.  Preexisting lung disease and lung cancer among nonsmoking women.

Authors:  M C Alavanja; R C Brownson; J D Boice; E Hock
Journal:  Am J Epidemiol       Date:  1992-09-15       Impact factor: 4.897

2.  Scar cancer of the lung: increase over a 21 year period.

Authors:  O Auerbach; L Garfinkel; V R Parks
Journal:  Cancer       Date:  1979-02       Impact factor: 6.860

3.  Airways obstruction and the risk for lung cancer.

Authors:  M S Tockman; N R Anthonisen; E C Wright; M G Donithan
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

4.  Pulmonary scar cancer. A pathologic reappraisal.

Authors:  I T Kung; I O Lui; S L Loke; M A Khin; C K Mok; W K Lam; S Y So
Journal:  Am J Surg Pathol       Date:  1985-06       Impact factor: 6.394

5.  Allergy-related diseases and cancer: an inverse association.

Authors:  J E Vena; J R Bona; T E Byers; E Middleton; M K Swanson; S Graham
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

6.  A meta-analysis of asthma and risk of lung cancer (United States).

Authors:  Alfredo A Santillan; Carlos A Camargo; Graham A Colditz
Journal:  Cancer Causes Control       Date:  2003-05       Impact factor: 2.506

Review 7.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action.

Authors:  S Ansar Ahmed; W J Penhale; N Talal
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

8.  Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States.

Authors:  A H Wu; E T Fontham; P Reynolds; R S Greenberg; P Buffler; J Liff; P Boyd; B E Henderson; P Correa
Journal:  Am J Epidemiol       Date:  1995-06-01       Impact factor: 4.897

9.  Inflammatory features of nasal mucosa in smokers with and without COPD.

Authors:  I Vachier; A M Vignola; G Chiappara; A Bruno; H Meziane; P Godard; J Bousquet; P Chanez
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

10.  Lung cancer among women in north-east China.

Authors:  A H Wu-Williams; X D Dai; W Blot; Z Y Xu; X W Sun; H P Xiao; B J Stone; S F Yu; Y P Feng; A G Ershow
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

View more
  5 in total

Review 1.  Identifying patterns of immune-related disease: use in disease prevention and management.

Authors:  Rodney R Dietert; Judith T Zelikoff
Journal:  World J Pediatr       Date:  2010-05-21       Impact factor: 2.764

2.  Cancer risk in chronic rhinosinusitis: a propensity score matched case-control cohort study.

Authors:  Chuan-Xin Xia; Yi-Wei Kao; Lei Qin; Ming-Chih Chen; Ben-Chang Shia; Szu-Yuan Wu
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

3.  Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.

Authors:  Jian-Min Yuan; Woon-Puay Koh; Sharon E Murphy; Yunhua Fan; Renwei Wang; Steven G Carmella; Shaomei Han; Katie Wickham; Yu-Tang Gao; Mimi C Yu; Stephen S Hecht
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

4.  The most important questions in cancer research and clinical oncology : Question 1. Could the vertical transmission of human papilloma virus (HPV) infection account for the cause, characteristics, and epidemiology of HPV-positive oropharyngeal carcinoma, non-smoking East Asian female lung adenocarcinoma, and/or East Asian triple-negative breast carcinoma?

Authors:  Joseph T S Wee; Sharon Shuxian Poh
Journal:  Chin J Cancer       Date:  2017-01-16

5.  Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.

Authors:  Ha Young Jang; In-Wha Kim; Jung Mi Oh
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.